• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿司匹林无反应状态与早期神经功能恶化:一项前瞻性研究。

Aspirin non-responder status and early neurological deterioration: a prospective study.

作者信息

Bugnicourt Jean-Marc, Roussel Bertrand, Garcia Pierre-Yves, Canaple Sandrine, Lamy Chantal, Godefroy Olivier

机构信息

Department of Neurology, Amiens University Hospital, and Laboratoire de Neurosciences Fonctionnelles et Pathologies, Place V Pauchet, 80000 Amiens, France.

出版信息

Clin Neurol Neurosurg. 2011 Apr;113(3):196-201. doi: 10.1016/j.clineuro.2010.11.004. Epub 2010 Dec 8.

DOI:10.1016/j.clineuro.2010.11.004
PMID:21145162
Abstract

OBJECTIVES

In acute ischemic stroke, early neurological deterioration (END) has a severe impact on patient outcome. We tested the hypothesis that initial biological aspirin non-responder status (ANRS) helps predict END.

METHODS

A total of 85 patients with acute ischemic stroke on 160mg aspirin daily were prospectively included. END was defined as an increase in the National Institutes of Health Stroke Scale (NIHSS) ≥4 points in the first 72h after admission. Platelet responsiveness to aspirin was assessed using the PFA-100 system, and ANRS was defined as a collagen/epinephrine closure time <165ms.

RESULTS

END was observed in 10 patients (11.8%). The presumed reasons for END were progressive stroke (40%), recurrent cerebral ischemia (30%), malignant middle cerebral artery infarction (20%) and secondary acute hydrocephalus (10%). Patients with END had a non-significant worse neurological status on the NIHSS at hospital admission (8.4 vs. 4.2; p=0.15). Initial impaired consciousness (30% vs. 3%), visual disturbance (60% vs. 23%) and ANRS (60% vs. 20%) were observed more frequently in patients with END. In multivariate analysis, impaired consciousness (OR: 17.3; 95% CI: 2.0-149.5; p=0.01) and ANRS (OR: 6.4; 95% CI: 1.4-29.6; p=0.017) were found to be independently associated with END.

CONCLUSION

ANRS is common in acute ischemic stroke patients and is predictive of END. The clinical significance of these findings requires further evaluation in larger longitudinal studies.

摘要

目的

在急性缺血性卒中中,早期神经功能恶化(END)对患者预后有严重影响。我们检验了初始生物阿司匹林无反应状态(ANRS)有助于预测END这一假设。

方法

前瞻性纳入85例每日服用160mg阿司匹林的急性缺血性卒中患者。END定义为入院后72小时内美国国立卫生研究院卒中量表(NIHSS)评分增加≥4分。使用PFA-100系统评估血小板对阿司匹林的反应性,ANRS定义为胶原/肾上腺素封闭时间<165毫秒。

结果

10例患者(11.8%)出现END。END的推测原因包括进展性卒中(40%)、复发性脑缺血(30%)、恶性大脑中动脉梗死(20%)和继发性急性脑积水(10%)。END患者入院时NIHSS神经功能状态较差,但差异无统计学意义(8.4对4.2;p=0.15)。与无END患者相比,END患者更常出现初始意识障碍(30%对3%)、视觉障碍(60%对23%)和ANRS(60%对20%)。多因素分析发现,意识障碍(OR:17.3;95%CI:2.0-149.5;p=0.01)和ANRS(OR:6.4;95%CI:1.4-29.6;p=0.017)与END独立相关。

结论

ANRS在急性缺血性卒中患者中常见,且可预测END。这些发现的临床意义需要在更大规模的纵向研究中进一步评估。

相似文献

1
Aspirin non-responder status and early neurological deterioration: a prospective study.阿司匹林无反应状态与早期神经功能恶化:一项前瞻性研究。
Clin Neurol Neurosurg. 2011 Apr;113(3):196-201. doi: 10.1016/j.clineuro.2010.11.004. Epub 2010 Dec 8.
2
Can aspirin resistance be clinically predicted in stroke patients?阿司匹林抵抗能否在卒中患者中进行临床预测?
Clin Neurol Neurosurg. 2008 Feb;110(2):110-6. doi: 10.1016/j.clineuro.2007.09.005. Epub 2007 Oct 26.
3
Plasma triglycerides as predictors of platelet responsiveness to aspirin in patients after first ischemic stroke.首次缺血性卒中后患者血浆甘油三酯作为血小板对阿司匹林反应性的预测指标
Cerebrovasc Dis. 2008;26(3):272-6. doi: 10.1159/000147455. Epub 2008 Jul 23.
4
Aspirin resistance and compliance with therapy.阿司匹林抵抗和治疗依从性。
Cardiovasc Ther. 2011 Oct;29(5):301-7. doi: 10.1111/j.1755-5922.2010.00188.x. Epub 2010 Jun 11.
5
Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.评估低至中等剂量阿司匹林在缺血性卒中和短暂性脑缺血发作早期及晚期的抗血小板作用。
Platelets. 2005 Aug;16(5):269-80. doi: 10.1080/09537100400020567.
6
Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke.急性缺血性卒中后阿司匹林和氯吡格雷治疗下血小板活化标志物的系列变化
Clin Neuropharmacol. 2010 Jan-Feb;33(1):40-5. doi: 10.1097/WNF.0b013e3181b8abc6.
7
Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke.曲氟尿苷和阿司匹林对急性缺血性中风患者炎症生物标志物的测量有不同影响。
Cerebrovasc Dis. 2009;28(4):371-7. doi: 10.1159/000230711. Epub 2009 Jul 30.
8
Aspirin responsiveness in acute brain ischaemia: association with stroke severity and clinical outcome.急性脑缺血中的阿司匹林反应性:与中风严重程度及临床结局的关联
Cerebrovasc Dis. 2008;25(4):355-61. doi: 10.1159/000118382. Epub 2008 Feb 28.
9
Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience.急性缺血性脑卒中患者使用600毫克氯吡格雷负荷剂量的安全性和耐受性:初步经验
Med Sci Monit. 2008 Oct;14(10):PI39-44.
10
Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?阿司匹林和氯吡格雷联合抗血小板治疗:急性缺血性卒中溶栓相关脑出血的危险因素?
J Neurol Sci. 2009 Sep 15;284(1-2):155-7. doi: 10.1016/j.jns.2009.05.003. Epub 2009 May 26.

引用本文的文献

1
Nomogram for predicting the occurrence of progressive ischemic stroke: a single-center retrospective study.预测进展性缺血性卒中发生的列线图:一项单中心回顾性研究
Eur J Med Res. 2025 Sep 26;30(1):880. doi: 10.1186/s40001-025-03171-5.
2
Relative score of early neurological deterioration in perforator artery infarction: a retrospective study.穿支动脉梗死患者早期神经功能恶化的相对评分:一项回顾性研究。
BMC Neurol. 2024 Aug 28;24(1):298. doi: 10.1186/s12883-024-03807-9.
3
Feasibility and comparability of different platelet function tests in acute stroke with or without prior antiplatelet therapy.
不同血小板功能检测在急性卒中伴或不伴既往抗血小板治疗情况下的可行性及可比性。
Front Neurol. 2024 Feb 12;15:1361751. doi: 10.3389/fneur.2024.1361751. eCollection 2024.
4
Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel.氯吡格雷相关基因变异与缺血性脑卒中患者氯吡格雷治疗后早期神经功能恶化
BMC Neurol. 2020 Apr 28;20(1):159. doi: 10.1186/s12883-020-01703-6.
5
Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.阿司匹林联合氯吡格雷可能降低携带 CYP2C19*2 功能降低等位基因的缺血性脑卒中患者早期神经功能恶化的风险。
J Neurol. 2018 Oct;265(10):2396-2403. doi: 10.1007/s00415-018-8998-1. Epub 2018 Aug 20.
6
Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.氯吡格雷和阿司匹林联合治疗可预防携带CYP2C19*2功能降低等位基因的缺血性中风患者早期神经功能恶化。
Eur J Clin Pharmacol. 2018 Sep;74(9):1131-1140. doi: 10.1007/s00228-018-2468-7. Epub 2018 May 26.
7
Response to clopidogrel is associated with early neurological deterioration after acute ischemic stroke.氯吡格雷反应与急性缺血性卒中后早期神经功能恶化相关。
Oncotarget. 2018 Apr 13;9(28):19900-19910. doi: 10.18632/oncotarget.24945.
8
Platelet function-guided modification in antiplatelet therapy after acute ischemic stroke is associated with clinical outcomes in patients with aspirin nonresponse.急性缺血性卒中后抗血小板治疗中基于血小板功能指导的调整与阿司匹林无反应患者的临床结局相关。
Oncotarget. 2017 Nov 7;8(63):106258-106269. doi: 10.18632/oncotarget.22293. eCollection 2017 Dec 5.
9
Interaction among COX-2, P2Y1 and GPIIIa gene variants is associated with aspirin resistance and early neurological deterioration in Chinese stroke patients.COX - 2、P2Y1和GPIIIa基因变异之间的相互作用与中国中风患者的阿司匹林抵抗和早期神经功能恶化有关。
BMC Neurol. 2017 Jan 9;17(1):4. doi: 10.1186/s12883-016-0788-8.
10
Antiplatelet drug resistance is associated with early neurological deterioration in acute minor ischemic stroke in the Chinese population.抗血小板药物抵抗与中国人群急性轻度缺血性卒中早期神经功能恶化相关。
J Neurol. 2016 Aug;263(8):1612-9. doi: 10.1007/s00415-016-8181-5. Epub 2016 Jun 3.